| ESMO consensus guidelines for the management of patients with metastatic colorectal cancer E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ... Annals of Oncology 27 (8), 1386-1422, 2016 | 4098 | 2016 |
| Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data M Maas, PJ Nelemans, V Valentini, P Das, C Rödel, LJ Kuo, FA Calvo, ... The lancet oncology 11 (9), 835-844, 2010 | 2294 | 2010 |
| Gastric cancer E Van Cutsem, X Sagaert, B Topal, K Haustermans, H Prenen The Lancet 388 (10060), 2654-2664, 2016 | 2148 | 2016 |
| ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making HJ Schmoll, E Van Cutsem, A Stein, V Valentini, B Glimelius, ... Annals of oncology 23 (10), 2479-2516, 2012 | 2046 | 2012 |
| Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M Ducreux, AS Cuhna, C Caramella, A Hollebecque, P Burtin, D Goéré, ... Annals of oncology 26, v56-v68, 2015 | 1770 | 2015 |
| Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up F Lordick, F Carneiro, S Cascinu, T Fleitas, K Haustermans, G Piessen, ... Annals of Oncology 33 (10), 1005-1020, 2022 | 1361 | 2022 |
| Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) M Bolla, H van Poppel, L Collette, P van Cangh, K Vekemans, L Da Pozzo, ... The Lancet 366 (9485), 572-578, 2005 | 1299 | 2005 |
| Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up F Lordick, C Mariette, K Haustermans, R Obermannová, D Arnold, ... Annals of Oncology 27, v50-v57, 2016 | 1113 | 2016 |
| Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) M Bolla, H van Poppel, B Tombal, K Vekemans, L Da Pozzo, ... The Lancet 380 (9858), 2018-2027, 2012 | 989 | 2012 |
| Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma P Flamen, A Lerut, E Van Cutsem, W De Wever, M Peeters, S Stroobants, ... Journal of Clinical Oncology 18 (18), 3202-3210, 2000 | 765 | 2000 |
| Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up A Oaknin, TJ Bosse, CL Creutzberg, G Giornelli, P Harter, F Joly, ... Annals of oncology 33 (9), 860-877, 2022 | 635 | 2022 |
| EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum CJH van de Velde, PG Boelens, JM Borras, JW Coebergh, A Cervantes, ... European journal of cancer 50 (1), 1. e1-1. e34, 2014 | 604 | 2014 |
| Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial LGW Kerkmeijer, VH Groen, FJ Pos, K Haustermans, EM Monninkhof, ... Journal of Clinical Oncology 39 (7), 787-796, 2021 | 554 | 2021 |
| Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ T Conroy, P Pfeiffer, V Vilgrain, A Lamarca, T Seufferlein, EM O’Reilly, ... Annals of oncology 34 (11), 987-1002, 2023 | 479 | 2023 |
| Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study DMJ Lambregts, V Vandecaveye, B Barbaro, FCH Bakers, M Lambrecht, ... Annals of surgical oncology 18 (8), 2224-2231, 2011 | 459 | 2011 |
| Multidisciplinary rectal cancer management: 2nd European rectal cancer consensus conference (EURECA-CC2) V Valentini, C Aristei, B Glimelius, BD Minsky, R Beets-Tan, JM Borras, ... Radiotherapy and oncology 92 (2), 148-163, 2009 | 421 | 2009 |
| Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer P Flamen, E Van Cutsem, A Lerut, JP Cambier, K Haustermans, ... Annals of Oncology 13 (3), 361-368, 2002 | 419 | 2002 |
| Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study JL Van Laethem, P Hammel, F Mornex, D Azria, G Van Tienhoven, ... Journal of clinical oncology 28 (29), 4450-4456, 2010 | 357 | 2010 |
| PET-based treatment planning in radiotherapy: a new standard? V Grégoire, K Haustermans, X Geets, S Roels, M Lonneux Journal of Nuclear Medicine 48 (1 suppl), 68S-77S, 2007 | 315 | 2007 |
| Mapping of pelvic lymph node metastases in prostate cancer S Joniau, L Van den Bergh, E Lerut, CM Deroose, K Haustermans, ... European urology 63 (3), 450-458, 2013 | 313 | 2013 |
